Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease

25Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Age-related androgen depletion has been implicated in compromised neuroprotection and is involved in the pathogenesis of neurodegenerative disease, including Alzheimer's disease (AD), the leading cause of dementia. Emerging data revealed that reduction of both serum and brain androgen levels in males is associated with increased amyloid-b (Ab) accumulation, a putative cause of AD. It has been demonstrated that androgens can function as the endogenous negative regulators of Ab. However, the mechanisms by which androgens regulate Ab production, degradation, and clearance, as well as the Ab-induced pathological process in AD, are still elusive. This review emphasizes the contributions of androgen to Ab metabolism and toxicity in AD and thus may provide novel strategies for prevention and therapeutics.

Cite

CITATION STYLE

APA

Lei, Y., & Renyuan, Z. (2018, December 1). Effects of Androgens on the Amyloid-β Protein in Alzheimer’s Disease. Endocrinology. Oxford University Press. https://doi.org/10.1210/en.2018-00660

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free